Location History:
- Pawcatuck, CT (US) (2007)
- Old Lyme, CT (US) (2007 - 2008)
Company Filing History:
Years Active: 2007-2008
Title: Discovering the Innovations of Christopher M Colangelo
Introduction:
Christopher M Colangelo, a talented inventor based in Old Lyme, CT (US), has made significant contributions to the field of nucleic acid sequencing. With a total of four patents to his name, Christopher's work at 454 Life Sciences Corporation has propelled the advancement of sequencing technologies.
Latest Patents:
1. "Apparatus and method for sequencing a nucleic acid": This patent introduces cutting-edge methods and apparatuses for sequencing nucleic acids. By enabling a high number of parallel sequencing reactions, this innovation allows for the simultaneous sequencing of over 10,000 different oligonucleotides.
2. "Method of sequencing a nucleic acid": Another patent by Christopher showcases methods for sequencing nucleic acids. By facilitating parallel sequencing reactions, this technique offers a streamlined approach to sequencing a large number of different oligonucleotides simultaneously.
Career Highlights:
Christopher M Colangelo's journey as an inventor has been marked by a dedication to advancing sequencing technologies. His innovative patents at 454 Life Sciences Corporation demonstrate a commitment to pushing the boundaries of nucleic acid sequencing and revolutionizing the field.
Collaborations:
Throughout his career, Christopher has had the privilege of working alongside esteemed colleagues such as Jonathan M Rothberg and Joel S Bader. These collaborations have fostered a dynamic environment for innovation, leading to groundbreaking advancements in the field of nucleic acid sequencing.
Conclusion:
In conclusion, Christopher M Colangelo stands out as a pioneering inventor in the realm of nucleic acid sequencing. His patents, especially the recent ones focusing on parallel sequencing reactions, exemplify his ingenuity and impact on the scientific community. Christopher's contributions have undoubtedly shaped the landscape of sequencing technologies, paving the way for future innovations in the field.